Trial NCT04119336

View at ClinicalTrials.gov 
Org. Study IDs: 19-283

Last trial update was posted on 2023-08-21

MeSH Interventions

Cyclophosphamide Dexamethasone Ixazomib Nivolumab

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Refractory Multiple Myeloma Relapsed Multiple Myeloma

Stopping Reasons

Study closure initiated by industry funding sponsor for commercial reasons.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID